Literature DB >> 16775578

Summary of notifiable diseases--United States, 2004.

Ruth Ann Jajosky, Patsy A Hall, Deborah A Adams, Felicia J Dawkins, Pearl Sharp, Willie J Anderson, J Javier Aponte, Gerald F Jones, David A Nitschke, Carol A Worsham, Nelson Adekoya, Timothy Doyle.   

Abstract

The Summary of Notifiable Diseases--United States, 2004 contains the official statistics, in tabular and graphic form, for the reported occurrence of nationally notifiable infectious diseases in the United States for 2004. Unless otherwise noted, the data are final totals for 2004 reported as of December 2, 2005. These statistics are collected and compiled from reports sent by state health departments to the National Notifiable Diseases Surveillance System (NNDSS), which is operated by CDC in collaboration with the Council of State and Territorial Epidemiologists (CSTE). The Summary is available at http://www.cdc.gov/mmwr/summary.html. This site also includes publications from previous years.

Entities:  

Mesh:

Year:  2006        PMID: 16775578

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  21 in total

1.  Graphic-output temperature data loggers for monitoring vaccine refrigeration: implications for pertussis.

Authors:  Patrick McColloster; Carlos Vallbona
Journal:  Am J Public Health       Date:  2010-11-18       Impact factor: 9.308

2.  Incidence and completeness of notification of Legionnaires' disease in The Netherlands: covariate capture-recapture analysis acknowledging regional differences.

Authors:  N A H Van Hest; C J P A Hoebe; J W Den Boer; J K Vermunt; E P F Ijzerman; W G Boersma; J H Richardus
Journal:  Epidemiol Infect       Date:  2007-06-22       Impact factor: 2.451

3.  Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies.

Authors:  L Coudeville; A van Rie; P Andre
Journal:  Epidemiol Infect       Date:  2007-07-05       Impact factor: 2.451

4.  Rubella Surveillance and Diagnostic Testing among a Low-Prevalence Population, New York City, 2012-2013.

Authors:  Beth M Isaac; Jane R Zucker; Francesca R Giancotti; Emily Abernathy; Joseph Icenogle; Jennifer L Rakeman; Jennifer B Rosen
Journal:  Clin Vaccine Immunol       Date:  2017-09-05

5.  Safety and immunogenicity of a live attenuated mumps vaccine: a phase I clinical trial.

Authors:  Yan Liang; Jingchen Ma; Changgui Li; Yuguo Chen; Longding Liu; Yun Liao; Ying Zhang; Li Jiang; Xuan-Yi Wang; Yanchun Che; Wei Deng; Hong Li; Xiaoyu Cui; Na Ma; Dong Ding; Zhongping Xie; Pingfang Cui; Qiuyan Ji; JingJing Wang; Yuliang Zhao; Junzhi Wang; Qihan Li
Journal:  Hum Vaccin Immunother       Date:  2014-03-10       Impact factor: 3.452

6.  Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010.

Authors:  Preeta Krishnan Kutty; Jacqueline Lawler; Elizabeth Rausch-Phung; Ismael R Ortega-Sanchez; Stephen Goodell; Cynthia Schulte; Lynn Pollock; Barbara Valure; Jean Hudson; Kathleen Gallagher; Debra Blog
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

7.  Author's Reply.

Authors:  M S Najar; C L Saldanha; K A Banday
Journal:  Indian J Nephrol       Date:  2010-04

8.  Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness.

Authors:  Douglas M Warner; William M Shafer; Ann E Jerse
Journal:  Mol Microbiol       Date:  2008-08-27       Impact factor: 3.501

9.  Primary and secondary cases in Escherichia coli O157 outbreaks: a statistical analysis.

Authors:  Kate G Snedeker; Darren J Shaw; Mary E Locking; Robin J Prescott
Journal:  BMC Infect Dis       Date:  2009-08-28       Impact factor: 3.090

10.  Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects.

Authors:  Laurent Coudeville; Annelies Van Rie; Denis Getsios; J Jaime Caro; Pascal Crépey; Van Hung Nguyen
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.